Form 4: DENTSPLY SIRONA Director Boosts Equity Holdings

DENTSPLY SIRONA Director Betsy D. Holden acquired 646.937 restricted stock units as dividends, increasing her beneficial ownership to 53,902.896 shares.

Summary

• Betsy D. Holden, a Director of DENTSPLY SIRONA Inc. (XRAY), acquired 646.937 shares of common stock on October 10, 2025.
• This acquisition represents dividends on previously awarded restricted stock units (RSUs) and was granted at a price of $0.
• The newly acquired RSUs are subject to the same vesting terms as the underlying awards and convert to common stock on a 1:1 basis.
• Following this transaction, Ms. Holden's direct beneficial ownership of DENTSPLY SIRONA common stock increased to 53,902.896 shares.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.
• The Form 4 reporting this transaction was filed on October 15, 2025.

Sentiment

Score: 7

Explanation: The transaction is a routine compensation event for a director, involving the acquisition of additional restricted stock units as dividends. It reflects standard corporate governance practices and increases the director's beneficial ownership, aligning interests with shareholders, which is generally viewed positively but not a significant market-moving event.

Positives

• Director's beneficial ownership increased, further aligning her interests with those of shareholders.
• The acquisition of additional RSUs as dividends indicates an ongoing, structured compensation plan for directors, which is a common practice for aligning long-term incentives.

Future Outlook

The acquired restricted stock units are subject to the same vesting terms as the underlying awards, implying future conversion to common stock upon satisfaction of those terms.

Industry Context

This transaction is a routine insider filing related to director compensation, a common practice across publicly traded companies in various sectors, including the dental products and technologies industry where DENTSPLY SIRONA operates. Such equity awards are designed to align the interests of directors with long-term shareholder value.

Comparison to Industry Standards

• The practice of awarding restricted stock units (RSUs) and dividends on those RSUs to directors is a common compensation practice in publicly traded companies, including those in the healthcare and medical device sectors. This aligns director incentives with long-term shareholder value, consistent with global benchmarks for executive and director compensation.

Related Party Transactions

• Acquisition of 646.937 restricted stock units by Director Betsy D. Holden as dividends on existing RSU awards, which is a standard component of director compensation and considered a related party transaction.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholders due to higher equity ownership, potentially fostering better long-term decision-making.

Next Steps

• The acquired restricted stock units will vest according to the terms of the underlying awards, eventually converting to common stock.

Key Dates

Keywords

DENTSPLY SIRONA, XRAY, Form 4, Insider Transaction, Restricted Stock Units, RSU Dividends, Director Compensation, Beneficial Ownership, Equity Award, Rule 10b5-1